Literature DB >> 30402176

Prevalence and Characteristic Features of Deep Venous Thrombosis in Patients with Severe Motor and Intellectual Disabilities.

Hiromitsu Ohmori1, Yasushi Kanaoka2, Masami Yamasaki3, Hiroko Takesue4, Ryo Sumimoto5.   

Abstract

Sudden death associated with patients with severe motor and intellectual disabilities (SMID) have been thought to be caused in part by venous thromboembolism (VTE), but actual situation of VTE in SMID is not clear. We examined the prevalence and location of deep venous thrombosis (DVT), and the relation of the development of crural veins in 16 patients with SMID, using ultrasonography. The maximum diameter of soleal vein was 1.6±0.5 mm. In most cases, DVT was found in the femoral veins. We could not detect thrombus in the soleal veins. In the present study, the detection ratio of DVT was high in patients with SMID who had restricted mobility capability and were bedridden, and we found the veins centrally from popliteal veins in DVT in SMID, not soleal veins, as the initial sites of the DVT. In the literature, the mean diameter of soleal veins, in healthy adults is 6.7±1.8 mm, that in contrast in SMID being smaller. Underdevelopment of intramuscular veins is possibly related to the mechanism of DVT in SMID. In the current guidelines for the management of VTE, there is limited in scope of ambulatory adults and no application cases who exhibit to SMID restricted mobility of the lower extremities and are bedridden associated with cerebral palsy and developmental motor disabilities, and such patients have associated high risk of the complications of DVT. According to our present study, it is necessary to provide appropriate guidelines for DVT in SMID considering characteristic features. (This is a translation of Jpn J Phlebol 2017; 28: 29-34.).

Entities:  

Keywords:  deep venous thrombosis; duplex ultrasonography; severe motor and intellectual disabilities (SMID); soleus vein

Year:  2018        PMID: 30402176      PMCID: PMC6200627          DOI: 10.3400/avd.oa.18-00028

Source DB:  PubMed          Journal:  Ann Vasc Dis        ISSN: 1881-641X


  6 in total

1.  Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.

Authors:  Harry R Büller; Hervé Décousus; Michael A Grosso; Michele Mercuri; Saskia Middeldorp; Martin H Prins; Gary E Raskob; Sebastian M Schellong; Lee Schwocho; Annelise Segers; Minggao Shi; Peter Verhamme; Phil Wells
Journal:  N Engl J Med       Date:  2013-08-31       Impact factor: 91.245

2.  Efficacy and safety of edoxaban for treatment of venous thromboembolism: a subanalysis of East Asian patients in the Hokusai-VTE trial.

Authors:  M Nakamura; Y Q Wang; C Wang; D Oh; W-H Yin; T Kimura; K Miyazaki; K Abe; M Mercuri; L H Lee; A Segers; H Büller
Journal:  J Thromb Haemost       Date:  2015-08-27       Impact factor: 5.824

3.  Guidelines for the diagnosis, treatment and prevention of pulmonary thromboembolism and deep vein thrombosis (JCS 2009).

Authors: 
Journal:  Circ J       Date:  2011-03-25       Impact factor: 2.993

4.  Deep Vein Thrombosis in Patients with Severe Motor and Intellectual Disabilities, Especially Diagnosis and Prevention of Recurrence for Chronic Thrombosis-Serial Changes of Sonography and D-Dimer.

Authors:  Hiromitsu Ohmori; Yasushi Kanaoka; Yoshio Murata; Masami Yamasaki; Hiroko Takesue; Nobuo Matsumoto; Ryo Sumimoto; Shigetsugu Ohgi
Journal:  Ann Vasc Dis       Date:  2015-10-16

5.  Pulmonary embolism in patients with isolated soleal vein thrombosis.

Authors:  S Ohgi; M Tachibana; M Ikebuchi; Y Kanaoka; T Maeda; T Mori
Journal:  Angiology       Date:  1998-09       Impact factor: 3.619

6.  Edoxaban versus warfarin in patients with atrial fibrillation.

Authors:  Robert P Giugliano; Christian T Ruff; Eugene Braunwald; Sabina A Murphy; Stephen D Wiviott; Jonathan L Halperin; Albert L Waldo; Michael D Ezekowitz; Jeffrey I Weitz; Jindřich Špinar; Witold Ruzyllo; Mikhail Ruda; Yukihiro Koretsune; Joshua Betcher; Minggao Shi; Laura T Grip; Shirali P Patel; Indravadan Patel; James J Hanyok; Michele Mercuri; Elliott M Antman
Journal:  N Engl J Med       Date:  2013-11-19       Impact factor: 91.245

  6 in total
  1 in total

1.  Deep Vein Thrombosis in Severe Motor and Intellectual Disabilities Patients and Its Treatment by Anticoagulants of Warfarin Versus Edoxaban.

Authors:  Hiromitsu Ohmori; Akiko Kada; Mashio Nakamura; Akiko M Saito; Yoshitami Sanayama; Tomoe Shinagawa; Hiroshi Fujita; Akiko Wakisaka; Keiko Maruhashi; Akiko Mizukami; Noboru Takizawa; Hiroaki Murata; Michiko Inoue; Hideo Kaneko; Hidekazu Taniguchi; Nozomi Sano; Naoyuki Tanuma; Masao Kumode; Tomoki Takechi; Yukihiro Koretsune; Ryo Sumimoto; Takeshi Miyanomae
Journal:  Ann Vasc Dis       Date:  2019-09-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.